a challenging odyssey through aml: confronting agvhd, tma, pres after allohct
Published 7 months ago • 261 plays • Length 36:06Download video MP4
Download video MP3
Similar videos
-
42:38
idh inhibitors in relapsed/refractory aml
-
34:52
measurable residual disease in acute myeloid leukemia mrd in aml
-
50:25
gvhd in 2022: from prevention to therapy
-
21:56
clinical pearls for the accurate diagnosis and optimal treatment of hereditary attr amyloidosis
-
1:01
the successes of the iach meeting
-
2:07
the clearance of driver mutations following allosct impacts myelofibrosis disease outcomes
-
1:08
iach 2020 welcome
-
1:13
the allg cml13 ascend-cml study: high major molecular responses with asciminib treatment for cp-cml
-
4:04
a2r # season 1 31 (iih looking beyond eye)
-
0:31
a preliminary investigation of human adaptations for various virtual eyes in video see-through hmds
-
2:38
unmet needs in imaging for the diagnosis of al amyloidosis
-
58:36
bispecific antibodies in multiple myeloma
-
1:47
individualized machine learning predictions of allosct outcomes in aml: the harmony platform
-
3:21
insights into the management of systemic al amyloidosis
-
1:30:24
cellular therapy - a post ash 2020 summary
-
1:01:22
chronic lymphocytic leukemia at ash21: what's new?